(Manila Bulletin File Photo)
DOST-PCHRD Executive Director Dr. Jaime C. Montoya noted that the Philippines had participated in the WHO Solidarity Treatment Trial of four repurposed antiviral drugs Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon beta-1a.
“Natapos na po ang ating participation sa WHO Solidarity Treatment Trial at tiningnan po ang apat na repurposed drugs kung sila ay makakatulong sa mga pasyenteng may COVID 19 kaya lang po base sa datos at analysis ng WHO dun sa mga datos na nakuha from the Philippines at sa ibang bansa ay mukhang wala po sa apat na repurposed drugs na ito ang makakatulong (Our participation in the WHO Solidarity Treatment Trial has ended and we have looked at four repurposed drugs if they can help patients with COVID 19, but based on WHO data and analysis of data obtained from the Philippines and other countries it seems that none of these four repurposed drugs can help),” he said during the Laging Handa briefing.
endIndex:
Metro Manila (CNN Philippines, May 20) The Philippines is nearing the finish line in terms of preparing for the upcoming solidarity vaccine trials of the World Health Organization, an official of the Department of Science and Technology said. pero tayo po ay kumbaga nasa last mile na sa paghahanda, DOST Philippine Council for Health Research and Development executive director Dr. Jaime Montoya told a televised government briefing Thursday.
[Translation: For now, the WHO solidarity vaccine trials haven t started but you could say we are in the last mile of preparations.]
Montoya added that the government is now finalizing the equipment to be used, and has been coordinating with the WHO in the transport of the necessary equipment and the training of healthcare workers who will take part in the trials.
May 20 is International Clinical Trials Day cnnphilippines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnnphilippines.com Daily Mail and Mail on Sunday newspapers.
Published May 17, 2021, 3:30 PM
As the lead agency for health and health-related research initiatives, Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) continues to support various health research projects and activities to help address the challenges brought by the coronavirus disease (COVID-19) pandemic in the country.
The DOST-PCHRD presented several health research projects and innovations related to COVID-19 during the “Talakayang HeaRTBeat” on May 17, 2021. (Screengrab from DOST PCHRD Facebook page)
During the virtual “Talakayang HeaRTBeat” on Monday, May 17, the DOST-PCHRD presented several health research projects and innovations that have already provided significant inputs and contributions in the field of diagnostics, public health surveillance, and treatment for COVID-19.
More than 1,200 local and international participants attended the webinar mainly composed of employees from DOST and other National Government Agencies (NGAs), State Universities and Colleges (SUCs), Higher Education Institutes (HEIs), Civil Society Organizations (CSOs), and private individuals. The webinar was made open to the public via Zoom and Facebook Live.
Recognizing that the sweeping societal change and the looming uncertainties in the country due to the COVID-19 can pose a serious threat to the well-being of the Filipinos, the Department of Science and Technology (DOST)-Mimaropa in partnership with the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) tapped Professor Raj Raghunathan, a world-renowned